De Novo Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Professionals
  • 3
Professionals
  • Investments
  • 129
  • Portfolio
  • 5
  • Exits
  • 58
Exits

De Novo Ventures General Information

Description

De Novo Ventures is a venture capital firm that specializes in the early stage to late stage investments. The firm Prefers to invest in the medical devices and biotechnology sectors. It is based in Saratoga, California and was founded in 2000.

Contact Information

Year Founded
2000
Investor Status
Not Making New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Post Office Box 2160
  • Saratoga, CA 95070
  • United States
+1 (650) 000-0000

De Novo Ventures Investments (129)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Pulmonx 05-May-2020 Later Stage VC 0000 Therapeutic Devices Generating Revenue/Not Profitable 0000000 0000000
00000000 0000000 06-Jan-2016 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 0000000
0000000 24-Sep-2014 00000 00000 0000 Drug Delivery Generating Revenue
00000000 0000000 18-Jun-2014 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 0000000
000000 00000000 02-Jun-2014 00000 00000 0000 Surgical Devices Generating Revenue 0000000 0000000
00000000000 000000 07-May-2014 00000 00000 000.00 Therapeutic Devices Generating Revenue 000000 0000000 00.0
0000000 17-Dec-2013 00000 00000 000.00 Drug Discovery Generating Revenue/Not Profitable
000000 00000000 12-Sep-2013 00000 00000 0000 Therapeutic Devices Profitable 0000000 0000000
Alcon and Wavetec Vision Systems 07-Jun-2013 Later Stage VC 0000 Surgical Devices Generating Revenue 000000 0000000 00.0
Benvenue Medical 22-May-2013 Later Stage VC 0000 Therapeutic Devices Generating Revenue 0000000 0000000
You’re viewing 10 of 129 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

De Novo Ventures Exits (58)

Company Name Exit Date Exit Type Exit Size
Viracta 24-Feb-2021 Reverse Merger
00000000 0000000 16-Dec-2020 0000000000
0000000 01-Oct-2020 000 00000
000000 21-Nov-2019 000000000000000000 00000
000000 00000000 09-Apr-2019 000000000000000000 00000
000000 14-Feb-2019 000 0000
0000000 19-Jul-2018 000 00000
000000 00000000 30-Apr-2018 000000000000000000 00000
Astute Medical 04-Apr-2018 Merger/Acquisition 0000
BioParadox 29-Dec-2017 Out of Business
You’re viewing 10 of 58 exits. Get the full list »

De Novo Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore De Novo Ventures‘s full profile, request access.

Request a free trial

De Novo Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

De Novo Ventures Team (9)

Name Title Deals Funds Boards Office
Frederick Dotzler Co-Founder & Managing Director 00 0 Saratoga, CA
Richard Ferrari Co-Founder & Managing Director 00 0 00 Saratoga, CA
Joseph Mandato Ph.D Managing Director 00 0 0 Saratoga, CA
You’re viewing 3 of 9 team members. Get the full list »

De Novo Ventures Co-Investors (14)

Name With Exits Lead Partner Series Industry
Boston Scientific 1 0 Series chart Industry bar
HealthCap 0 0 Series chart Industry bar
Kleiner Perkins 0 0 Series chart Industry bar
Latterell Venture Partners 0 0 Series chart Industry bar
MedVenture Associates 0 0 Series chart Industry bar
You’re viewing 5 of 14 co-investors. Get the full list »